<DOC>
	<DOC>NCT01618695</DOC>
	<brief_summary>The purpose of this study is to confirm the efficacy and safety of perampanel compared to placebo in patients with refractory partial-onset seizures</brief_summary>
	<brief_title>A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<criteria>Inclusion Criteria 1. Male or female and greater than or equal to 12 years of age; 2. Have a diagnosis of epilepsy with partial seizures with or without secondarily generalized seizures 3. Subjects with computed tomography (CT) or magnetic resonance imaging (MRI) diagnosis 4. Subjects who had been treated for at least 12 weeks but confirmed to be uncontrolled with more than one standard AED for 2 years before enrollment 5. During the 6week Prerandomization Phase subjects must have had greater than or equal to 5 partial seizures per 6week 6. Are on a stable dose and administration of the same concomitant AED(s) for 1 month prior to Visit 1 Exclusion Criteria 1. Presence of nonmotor simple partial seizures only; 2. Presence of primary generalized epilepsies or seizures, such as absences and/or myoclonic epilepsies; 3. Presence or previous history of LennoxGastaut syndrome; 4. A history of status epilepticus within 1 year before enrollment in Prerandomization Phase 5. Seizure clusters where individual seizures cannot be counted 6. A history of psychogenic seizures within 5 years before enrollment in Prerandomization Phase</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Partial-onset Seizures</keyword>
	<keyword>partial seizures</keyword>
	<keyword>seizure</keyword>
	<keyword>epilepsy</keyword>
</DOC>